Target intelligence / Profile preview

Prolactin (PRL)

Target
PRL
Molecular classification
Hormone, Protein hormone, Cytokine-like hormone
01

Overview

Prolactin is a protein hormone primarily produced by the anterior pituitary gland's lactotroph cells. It plays a central role in initiating and maintaining milk production in mammals but also has over 300 distinct biological functions across vertebrates. These include promoting mammary gland growth and differentiation, regulating reproductive function by inhibiting gonadotropins during high serum levels (such as during breastfeeding), modulating immune responses, influencing metabolism and pancreatic development, acting as a growth factor with anti-apoptotic properties, and participating in hematopoiesis and angiogenesis. Prolactin secretion is tightly regulated—mainly inhibited by hypothalamic dopamine—and can be stimulated by factors such as estrogen or thyrotropin-releasing hormone. Disorders involving abnormal prolactin secretion include hyperprolactinemia and prolactinoma; these are often treated with dopamine agonist drugs like bromocriptine or cabergoline that suppress its release from the pituitary gland[1][2][3][4][5].\n\nNote on target validity: "Prolactin secretion" itself is not a molecule or receptor but rather a physiological process describing the release of the hormone prolactin from cells. The actual molecular target relevant to drug action would be either "Prolactin" (the protein/hormone) or "Prolactin receptor." Therefore:\n\nis_incorrect = true\n\nbecause "prolactin secretion" does not refer to a discrete molecular entity suitable for direct pharmacological targeting; it describes an event/process rather than a specific therapeutic target molecule/receptor.

Other names
lactotropinmammotropinluteotropic hormone (LTH)luteotropin
02

Mechanism of action

Dopamine agonists inhibit prolactin secretion by stimulating D2 receptors on pituitary lactotrophs[5]

03

Biological functions

Initiation and maintenance of lactationMammary gland developmentRegulation of reproductive function and fertilityModulation of immune system activityMetabolic regulation (including pancreatic development)
04

Disease associations

Hyperprolactinemia (can cause infertility, galactorrhea)Prolactinoma (pituitary tumor)
05

Safety considerations

Dopamine agonists may cause nausea, vomiting, headaches; risk of psychiatric side effects in some patients[5]
06

Interacting drugs

Bromocriptine

1 more in the full profile.

07

Biomarkers

Serum prolactin concentration for diagnosis/monitoring of pituitary disorders or hyperprolactinemia[2][5]

Beyond the preview

Go deeper on Prolactin (PRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolactin (PRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call